Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    New Treatment Strategy Improves Depression in Patients With Cancer - (DGNews)
    TopAbstracts in Depression 07/02/2008 - (DGNews)
    TopAbstracts in Depression 06/25/2008 - (DGNews)
    TopAbstracts in Depression 06/18/2008 - (DGNews)
    Pregabalin Effective for Fibromyalgia Pain Regardless of Patient Anxiety or Depression: Presented at EULAR - (DGDispatch)

    News archive

     Recent webcasts/CME - Depression
    • Understanding and Managing the Fibromyalgia Syndrome
    • Accurate Diagnosis of Fibromyalgia Is Essential for Effective Management
    • Recognition and Management of Depression
      Understanding the Vital Link: Depression and Chronic Disease
      Female Sexual Dysfunction and Depression: Addressing Cause and Effect

      Webcasts/CME archive

       Recent cases - Depression
        Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report
        Dissecting the Determinants of Depressive Disorders Outcome: An in Depth Analysis of Two Clinical Cases
        Incomplete Oedipism and Chronic Suicidality in Psychotic Depression with Paranoid Delusions Related to Eyes
        Excessive Weight Gain after Remission of Depression in a Schizophrenic Patient Treated with Risperidone: Case Report
        Fluoxetine Withdrawal Syndrome in the Newborn

        Cases archive
          




        my personal edition > depression > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Milnacipran Effective In Post-Stroke Depression

        A DGReview of :"Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression"
        International Clinical Psychopharmacology

        05/29/2002
        By Elda Hauschildt


        Milnacipran, a serotonin and noradrenaline reuptake inhibitor (SNRI), may be effective in treating post-stroke depression.

        Japanese researchers from Nippon Medical School and Matsue Hospital in Tokyo and Imai Hospital in Akita evaluated SNRI efficacy and safety in 12 patients with post-stroke depression.

        Other studies have assessed the use of selective serotonin reuptake inhibitors (SSRIs) and tricyclics as treatment for post-stroke depression, but the researchers say this is the first to look at the effects of a SNRI.

        Two men and 10 women, aged 53 to 88 years, participated in the six-week open trial. All had been diagnosed with major or minor depressive disorder, onset was subsequent to a cerebral infarction or haemorrhage.

        Severity of depression was assessed using the 21-item Hamilton rating scale for depression (HAM-D).

        The researchers report that the maximum daily dose of milnacipran was in the range of 30 milligrams to 75 mg twice a day.

        Three patients experienced side effects although none were serious. Two patients dropped out.

        By the end of six weeks, seven of the 12 patients (58.3 percent) and seven of the 10 completing the study (70 percent) were in remission as defined remission by a final HAM-D score of less than seven and by no longer meeting criteria for major or minor depression.
        International Clinical Psychopharmacology, 2002; 17: 121-125. "Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send